NU reports earnings today after the close. Options traders are the loudest signal in the room right now.
The put-call ratio hit 0.7349 on May 13 — a 52-week high. The z-score of 2.57 puts that reading more than two and a half standard deviations above the 20-day mean of 0.62. The stock is down 14% over the past month. Traders are buying puts at the highest relative rate in a year, right before the number drops.
The PCR surge is notable for its timing. For most of the past month, the ratio sat in a tight band between 0.54 and 0.70. It broke sharply higher in a single session. That kind of one-day spike into a 52-week extreme — with a z-score above 2.5 — signals an unusual cluster of hedging or directional put activity, not routine flow.
Prior earnings have not been kind. The February 2026 print sent the stock down 8.9% in one day and 9.3% over the following week. Traders appear to be pricing in that risk again.
Short interest rose 11.7% over the past week to 3.72% of free float — roughly 142 million shares. That is a meaningful directional move, even if the absolute level remains modest. Shorts have been adding steadily through May.
What's unusual is the simultaneous collapse in cost to borrow. CTB dropped 63% over the week to just 0.17% annually — the cheapest it has been in the data window. The lending market is wide open. Availability is high, meaning plenty of shares remain in the pool relative to what's already borrowed. Building a short position right now costs almost nothing.
The mean analyst price target stands at $19.87 — 55% above Tuesday's close of $12.82. CICC initiated coverage on April 14 with an Outperform rating and an $18 target. UBS upgraded to Buy in March, raising its target to $17.60. The analyst community has not moved materially bearish despite the sell-off.
That gap — bullish analyst consensus, falling stock, rising shorts, and a put-heavy options market — is the tension that earnings will resolve one way or the other.
BlackRock added over 20.5 million shares as of April 30, lifting its stake to 6.6% of shares outstanding. FMR (Fidelity) added nearly 5 million shares in the same period. Large institutional holders are not reducing exposure.
See the live data behind this article on ORTEX.
Open NU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
